Results 141 to 150 of about 5,275,021 (315)

Emotion Regulation Difficulties in Autism‐PTSD Co‐Occurrence

Autism Research, EarlyView.
ABSTRACT Autistic individuals face an increased risk of experiencing traumatic events and of being significantly affected by them, whether these events are life‐threatening or social in nature. Emotion regulation (ER) difficulties are central to both conditions, yet their role in this neuropsychiatric co‐occurrence remains under‐researched.
Eldar Fayena, Shir Shaked‐Ashkenazi, Michal Shoval, Mordi Benhamou, Nathaniel Laor, Danny Horesh, Ofer Golan   +6 more
wiley   +1 more source

Evaluation of Correlation between C-reactive Protein (CRP) Levels in Synovial Lavage Fluid and Clinical Staging of Temporomandibular Joint Internal Derangement Disorders by Diagnostic Arthroscopy: A Prospective Study

Journal of Orofacial Sciences
Introduction: Pain in the temporomandibular joint (TMJ) is thecommonsymptom in the patients with TMD. Unfortunately, the factors mediating pain are not sufficiently known to permitspecific treatment.
Mayank Singhal, Manoj Goyal, D.S. Gupta, Saurabh Bhardwaj   +3 more
doaj   +1 more source

Enhancing Annular Fissures and High-Intensity Zones: Pain, Internal Derangement, and Anesthetic Response at Provocation Lumbar Discography. [PDF]

AJNR Am J Neuroradiol, 2023
Bartynski WS, Agarwal V, Trang H, Bandos AI, Rothfus WE, Tsay J, Delfyett WT, Nastasi B.   +7 more
europepmc   +1 more source

Osteoarthritis in temporomandibular joint internal derangement [Elektronisk resurs]

, 2004
Internal derangement of the temporomandibular joint is the most common diagnosis leading to joint surgery. Two variants of internal derangement exist, painful clicking and chronic closed lock.
Paegle, D,
core  

Ceftriaxone‐induced liver injury: Incidence, phenotypic characterization and predictive factors

British Journal of Clinical Pharmacology, EarlyView.
Introduction Ceftriaxone is a widely used third‐generation cephalosporin in hospitalized patients. Although generally considered safe, it has been associated with hepatobiliary complications and emerging reports of drug‐induced liver injury (DILI). However, data on its true incidence, phenotypic patterns, and predictors remain limited. This study aimed
Mohamed Hatem, Mohannad N. AbuHaweeleh, Humam Emad Rajha, Mhd Osama Rahhal, Ahmad Hamdan, Lina Naseralallah   +5 more
wiley   +1 more source

RDC/TMD axis II criteria in defining temporomandibular disorders. a cross-sectional study

BMC Oral Health
Background This cross-sectional study analyzed patients with temporomandibular joint disorders (TMD) through the Research Diagnostic Criteria Axis II and compared the outcomes in patient groups separated according to the Okeson Classification.
Muhsin Ardıç, Melike Yalçıntaş Ardıç, Bülent Kahraman, Poyzan Bozkurt, Cahit Üçok   +4 more
doaj   +1 more source

Gabapentinoids‐duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting

British Journal of Clinical Pharmacology, EarlyView.
Chronic pain represents a complex debilitating condition that extends beyond the protective function of physiological pain, often persisting as an independent disease entity. Chronic primary and secondary pain syndromes reflect a multifaceted continuum involving nociceptive, neuropathic and nociplastic mechanisms.
Stefania Nobili, Maurizio Evangelista, Elena Lucarini, Elena G. Giugliano, Carla Ghelardini, Laura Micheli, Lorenzo Di Cesare Mannelli   +6 more
wiley   +1 more source

Arthrocentesis Versus Level 1 Arthroscopy in Internal Derangement of Temporomandibular Joint. [PDF]

J Maxillofac Oral Surg, 2023
Rajpoot D, Anchlia S, Bhatt U, Dhuvad J, Patel H, Mansuri Z.   +5 more
europepmc   +1 more source

INTERNAL DERANGEMENTS OF THE KNEE-JOINT [PDF]

BMJ, 1918
openaire   +2 more sources

Efficacy and safety of cannabinoids in the treatment of spasticity in multiple sclerosis: A systematic review of randomized clinical trials

British Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to evaluate the efficacy and safety of cannabinoids for the treatment of MS‐related spasticity. Methods Systematic searches were conducted in PubMed, EMBASE, and LILACS on 2 December 2025. Randomized controlled trials evaluating natural or synthetic cannabinoids for MS‐related spasticity were included.
Letícia Hamm‐Buiar, Daniela Gorski, Marcela Harumi Kagueiama, Astrid Wiens   +3 more
wiley   +1 more source